Sisram Medical Ltd has issued a notice convening its Annual General Meeting for 24 June 2026 at 2:00 p.m. in the Renaissance Hong Kong Harbour View Hotel. Key items on the agenda include:

• Financial Reporting: Shareholders will vote to receive the audited consolidated financial statements and directors’ and auditors’ reports for the year ended 31 December 2025.

• Board Composition: Proposals call for the re-election of Executive Directors Lior Moshe Dayan and Jiahong Li, and Non-executive Directors Yi Liu and Caroline Xiaokui Jin.

• Auditor Appointment: Ernst & Young is nominated for re-appointment, with the board authorised to fix remuneration.

• Share Buy-back Mandate: Directors seek authority to repurchase up to 10% of the company’s issued share capital (excluding treasury shares) during the mandate period.

• Issuance Mandate: A separate resolution requests authority to allot and issue up to 20% of the issued share capital, excluding shares issued via rights issues, share schemes or scrip dividends. An additional resolution proposes extending this mandate by the number of shares bought back, capped at a further 10%.

• External Directors: Independent Non-executive Directors Heung Sang Addy Fong and Chi Fung Leo Chan are nominated for a fourth three-year term as external directors under Israeli Companies Law. Shareholders must declare any personal interest in these resolutions when voting.

Administrative details include a poll-based voting system, a record date of 24 June 2026, and a closure of the register of members from 18–24 June 2026. Proxy forms must be lodged by 2:00 p.m. on 22 June 2026. No food, corporate gifts or vouchers will be distributed at the meeting.